Temporal differences in culturable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) from the respiratory and gastrointestinal tracts in a patient with moderate coronavirus disease 2019 (COVID-19).
作者信息
Audsley Jennifer M, Holmes Natasha E, Mordant Francesca L, Douros Celia, Zufan Sara E, Nguyen Thi H O, Kedzierski Lukasz, Rowntree Louise C, Hensen Luca, Subbarao Kanta, Kedzierska Katherine, Nicholson Suellen, Sherry Norelle, Thevarajan Irani, Tran Thomas, Druce Julian
机构信息
Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Department of Infectious Diseases, Austin Hospital, Heidelberg, Australia.
出版信息
Infect Control Hosp Epidemiol. 2022 Sep;43(9):1286-1288. doi: 10.1017/ice.2021.223. Epub 2021 May 10.
Abstract
摘要
相似文献
1
Temporal differences in culturable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) from the respiratory and gastrointestinal tracts in a patient with moderate coronavirus disease 2019 (COVID-19).一名中度新型冠状病毒肺炎（COVID-19）患者呼吸道和胃肠道中可培养的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的时间差异
Infect Control Hosp Epidemiol. 2022 Sep;43(9):1286-1288. doi: 10.1017/ice.2021.223. Epub 2021 May 10.
2
May we learn a useful lesson from prevention rules against severe acute respiratory coronavirus virus 2 (SARS-CoV-2)?我们能从针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的预防规则中学到有用的经验教训吗？
Infect Control Hosp Epidemiol. 2021 Oct;42(10):1290-1291. doi: 10.1017/ice.2020.1228. Epub 2020 Sep 23.
3
Finding the off-ramp: Rethinking severe acute respiratory coronavirus virus 2 (SARS-CoV-2) preoperative screening.找到匝道：重新思考严重急性呼吸综合征冠状病毒2（SARS-CoV-2）术前筛查
Infect Control Hosp Epidemiol. 2022 Jul;43(7):918-919. doi: 10.1017/ice.2022.2. Epub 2022 Jan 6.
4
Vaccination remains the first choice to control the spread of delta and other variants of severe acute respiratory coronavirus virus 2 (SARS-CoV-2).接种疫苗仍然是控制新冠病毒（SARS-CoV-2）德尔塔及其他变异毒株传播的首要选择。
Infect Control Hosp Epidemiol. 2022 Nov;43(11):1749-1750. doi: 10.1017/ice.2021.364. Epub 2021 Aug 6.
5
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection.严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）：一种全身性感染。
Clin Microbiol Rev. 2021 Jan 13;34(2). doi: 10.1128/CMR.00133-20. Print 2021 Mar 17.
6
The challenges of education in a continental country in the face of new severe acute respiratory coronavirus virus 2 (SARS-CoV-2) variant circulation.一个大陆国家在新型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变种传播面前面临的教育挑战。
Infect Control Hosp Epidemiol. 2022 Oct;43(10):1537-1539. doi: 10.1017/ice.2021.291. Epub 2021 Jun 24.
7
Lack of Susceptibility to SARS-CoV-2 and MERS-CoV in Poultry.家禽对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）和中东呼吸综合征冠状病毒（MERS-CoV）不敏感。
Emerg Infect Dis. 2020 Dec;26(12):3074-3076. doi: 10.3201/eid2612.202989.
8
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染：综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
9
Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.概述：严重急性呼吸系统综合征的历史和儿科视角：新型还是类似 SARS。
Pediatr Pulmonol. 2020 Jul;55(7):1584-1591. doi: 10.1002/ppul.24810. Epub 2020 Jun 1.
10
[Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].[2019冠状病毒病及严重急性呼吸综合征冠状病毒2的诊断、治疗、控制与预防：回归未来]
Sheng Wu Gong Cheng Xue Bao. 2020 Apr 25;36(4):571-592. doi: 10.13345/j.cjb.200115.
本文引用的文献
1
Evolution of antibody immunity to SARS-CoV-2.SARS-CoV-2 抗体免疫的演变。
Nature. 2021 Mar;591(7851):639-644. doi: 10.1038/s41586-021-03207-w. Epub 2021 Jan 18.
2
Probable Evidence of Fecal Aerosol Transmission of SARS-CoV-2 in a High-Rise Building.高层建筑物中 SARS-CoV-2 粪便气溶胶传播的可能证据。
Ann Intern Med. 2020 Dec 15;173(12):974-980. doi: 10.7326/M20-0928. Epub 2020 Sep 1.
3
Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis.2019 年冠状病毒病患者的胃肠道症状和粪便病毒脱落的流行情况：系统评价和荟萃分析。
JAMA Netw Open. 2020 Jun 1;3(6):e2011335. doi: 10.1001/jamanetworkopen.2020.11335.
4
Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19.粪便中严重 COVID-19 患者的感染性 SARS-CoV-2。
Emerg Infect Dis. 2020 Aug;26(8):1920-1922. doi: 10.3201/eid2608.200681. Epub 2020 May 18.
5
Case Report: Viral Shedding for 60 Days in a Woman with COVID-19.病例报告：一名 COVID-19 女性患者病毒脱落 60 天。
Am J Trop Med Hyg. 2020 Jun;102(6):1210-1213. doi: 10.4269/ajtmh.20-0275.
6
Put a lid on it: are faecal bio-aerosols a route of transmission for SARS-CoV-2?盖上盖子：粪便生物气溶胶是新冠病毒的传播途径吗？
J Hosp Infect. 2020 Jul;105(3):397-398. doi: 10.1016/j.jhin.2020.04.024. Epub 2020 Apr 18.
7
Prolonged presence of SARS-CoV-2 viral RNA in faecal samples.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒RNA在粪便样本中的长期存在。
Lancet Gastroenterol Hepatol. 2020 May;5(5):434-435. doi: 10.1016/S2468-1253(20)30083-2. Epub 2020 Mar 20.
8
Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient.一名免疫功能低下患者体内多重耐药甲型流感病毒的长期排毒
N Engl J Med. 2003 Feb 27;348(9):867-8. doi: 10.1056/NEJM200302273480923.
9
Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis.免疫缺陷患者长期排出金刚烷胺耐药甲型流感病毒：通过聚合酶链反应-限制性分析进行检测
J Infect Dis. 1995 Nov;172(5):1352-5. doi: 10.1093/infdis/172.5.1352.
Zotero 插件